Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Brodeur

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Medical and Pediatric Oncology|December 7, 2000
Meeting summary for Advances in Neuroblastoma Research--2000G M Brodeur
Brain Pathology (Zurich, Switzerland)|September 1, 1990
Neuroblastoma--clinical applications of molecular parametersG M Brodeur
Progress in Hematology|January 1, 1986
Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activationG M Brodeur
The New England Journal of Medicine|March 3, 1994
The NF1 gene in myelopoiesis and childhood myelodysplastic syndromesG M Brodeur
Advances in Pediatrics|January 1, 1987
The involvement of oncogenes and suppressor genes in human neoplasiaG M Brodeur
Cancer Surveys|January 1, 1990
Neuroblastoma: clinical significance of genetic abnormalitiesG M Brodeur
Nature Medicine|March 1, 1995
Do the ends justify the means?G M Brodeur
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Molecular basis for heterogeneity in human neuroblastomasG M Brodeur
The New England Journal of Medicine|June 6, 1996
Schwann cells as antineuroblastoma agentsG M Brodeur
Seminars in Diagnostic Pathology|May 1, 1994
Molecular pathology of human neuroblastomasG M Brodeur
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Medical and Pediatric Oncology|December 7, 2000
Meeting summary for Advances in Neuroblastoma Research--2000G M Brodeur
Brain Pathology (Zurich, Switzerland)|September 1, 1990
Neuroblastoma--clinical applications of molecular parametersG M Brodeur
Progress in Hematology|January 1, 1986
Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activationG M Brodeur
The New England Journal of Medicine|March 3, 1994
The NF1 gene in myelopoiesis and childhood myelodysplastic syndromesG M Brodeur
Advances in Pediatrics|January 1, 1987
The involvement of oncogenes and suppressor genes in human neoplasiaG M Brodeur
Cancer Surveys|January 1, 1990
Neuroblastoma: clinical significance of genetic abnormalitiesG M Brodeur
Nature Medicine|March 1, 1995
Do the ends justify the means?G M Brodeur
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Molecular basis for heterogeneity in human neuroblastomasG M Brodeur
The New England Journal of Medicine|June 6, 1996
Schwann cells as antineuroblastoma agentsG M Brodeur
Seminars in Diagnostic Pathology|May 1, 1994
Molecular pathology of human neuroblastomasG M Brodeur
Pageof 21